How the US is preparing for flu season: 6 things to know
(By Mackenzie Bean for Becker’s Hospital Review) Federal health officials and drugmakers are taking several steps to boost flu vaccinations this
Read More
Part D/Prescription Drugs
Vast majority of Part D plan formularies are designed to encourage the use of generic drugs
An estimated $98 billion in Medicare Part D prescription drug spending in 2019, plan sponsors can affect overall retail drug
Read MoreMedicare Part D coverage varies based on the medication tiers
Medicare Part D is available through private insurance providers and can be used for prescription drug coverage. The different plans
Read MoreSpecialty drug price caps drastically reduce out-of-pocket costs without increasing health plan spending
(By Katie Adams for Becker’s Hospital Review) States that implemented out-of-pocket price caps for expensive specialty drugs saw patient spending
Read MorePharma is showering Congress with cash, even as drug makers race to fight the coronavirus
(By Lev Facher for STAT) WASHINGTON — The world’s biggest drug makers and their trade groups have cut checks to
Read MoreThe FDA accepted Biogen’s Alzheimer’s drug submission. Next up, a highly anticipated outside expert review
(By Adam Feuerstein for STAT) The Food and Drug Administration has agreed to review a marketing application submitted by Biogen
Read MoreModerna will charge $32 to $37 for COVID-19 vaccine, CEO says
(By Katie Adams for Becker’s Hospital Review) Moderna plans to charge $32 to $37 per dose for customers buying small orders of its
Read MoreTrump to order government to buy certain drugs solely from U.S. factories, setting up major shakeup for industry
(By Nicholas Florko for STAT) WASHINGTON — President Trump will sign an executive order Thursday directing the federal government to
Read MoreHave you updated your powers-of-attorney?
There are two different kinds of powers of attorney: financial and medical. A financial power of attorney document allows an
Read MoreHenry Ford researchers defend hydroxychloroquine study, slam politics surrounding drug
(By Gabrielle Masson for Becker’s Hospital Review) The persisting political climate has made any objective discussion about hydroxychloroquine “impossible,” two
Read More